A round-up of recent developments in the clinical research arena includes an expansion for NexMed’s pre-clinical division, acquisitions for Medpace …

A new King’s Fund report on how the NHS has fared under 13 years of Labour government has concluded that …
The idea of the ‘Matrix Organisation’ has caught on in recent years, but what is it exactly, and what are …

Phil Krzyzek has joined Quintiles as UK business development director for its Commercial business. Phil was most recently a marketing …
The recently retired head of Roche’s pharma division has called for more public-private partnerships in the pharma industry. William Burns …

Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …
Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …

The European Alliance for Access to Safe Medicines (EAASM) has appointed Mike Isles executive director. He was most recently at …

US biotech giant Genentech has officially opened its new 296,000 sq. ft. biologics manufacturing facility in Hillsboro, near Portland, Oregon. …

AstraZeneca has defeated another US lawsuit seeking compensation for diabetes side-effects allegedly caused by its drug Seroquel. A US Federal …

It will come as no surprise when I say that humour in healthcare advertising is a rare occurrence. So why …

Kajsa Wilhelmsson has joined Edelman’s health practice as director of European health public affairs. She will be based in the …
Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …

The UK government has agreed a deal with GlaxoSmithKine on surplus supplies of its H1N1 vaccine Pandemrix. The Department of …
Three UK pharma companies have been ‘named and shamed’ for serious breaches of the ABPI’s Code of Practice. Solvay, Pfizer …
Sigma-Aldrich has increased its high-potency active pharmaceutical ingredient (HPAPI) production capacity with the opening of a newly-expanded facility that is …
GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
A new healthcare industry marketing consultancy based in the North West of England has been launched. Strategic North is a …
Global communications group Publicis has acquired Toronto-based In-Sync, a company specialising in healthcare market research. In-Sync will become part of …